이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
WA
Based on Analyst Price Targets
EVO ICL Technology Transforms Vision Care, Securing Major Growth And Market Share Expansion
US$50.49
FV
26.3% undervalued intrinsic discount15.17%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
15 days agoauthor updated this narrative
STAAR Surgical Company 경쟁사
가격 내역 및 성능
| 과거 주가 | |
|---|---|
| 현재 주가 | US$37.23 |
| 52주 최고치 | US$52.68 |
| 52주 최저치 | US$26.66 |
| 베타 | 0.59 |
| 11개월 변경 | 12.51% |
| 3개월 변경 사항 | -21.49% |
| 1년 변경 사항 | -7.34% |
| 33년 변화 | -70.87% |
| 5년 변화 | 45.26% |
| IPO 이후 변화 | 56.76% |
최근 뉴스 및 업데이트
STAAR Surgical: Expecting A Re-Acceleration In Growth As Investments Materialize
Sep 05Results: STAAR Surgical Company Exceeded Expectations And The Consensus Has Updated Its Estimates
Aug 10
STAAR Surgical Company's (NASDAQ:STAA) Popularity With Investors Is Clear
Aug 05Recent updates
STAAR Surgical: Expecting A Re-Acceleration In Growth As Investments Materialize
Sep 05Results: STAAR Surgical Company Exceeded Expectations And The Consensus Has Updated Its Estimates
Aug 10STAAR Surgical Company's (NASDAQ:STAA) Popularity With Investors Is Clear
Aug 05The Returns At STAAR Surgical (NASDAQ:STAA) Aren't Growing
Jul 12Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?
May 27Market Participants Recognise STAAR Surgical Company's (NASDAQ:STAA) Revenues Pushing Shares 30% Higher
Apr 26STAAR Surgical Stock: I Don't See A Great Path Forward, Despite The Recent Surge
Apr 05STAAR Surgical (NASDAQ:STAA) Shareholders Will Want The ROCE Trajectory To Continue
Mar 25STAAR Surgical Company: Potential Buy After Long-Term Valuation Downgrade
Mar 13STAAR Surgical Company (NASDAQ:STAA) Looks Just Right With A 28% Price Jump
Mar 07Is There Now An Opportunity In STAAR Surgical Company (NASDAQ:STAA)?
Jan 31With STAAR Surgical Company (NASDAQ:STAA) It Looks Like You'll Get What You Pay For
Jan 05Returns On Capital Are Showing Encouraging Signs At STAAR Surgical (NASDAQ:STAA)
Nov 30Is There An Opportunity With STAAR Surgical Company's (NASDAQ:STAA) 21% Undervaluation?
Nov 12Is STAAR Surgical Company (NASDAQ:STAA) Potentially Undervalued?
Oct 25Returns On Capital At STAAR Surgical (NASDAQ:STAA) Have Hit The Brakes
Aug 24Are STAAR Surgical Company (NASDAQ:STAA) Investors Paying Above The Intrinsic Value?
Jul 02Is Now The Time To Look At Buying STAAR Surgical Company (NASDAQ:STAA)?
Jun 17Here's Why We Think STAAR Surgical (NASDAQ:STAA) Might Deserve Your Attention Today
May 13A Look At The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)
Mar 26STAAR Surgical (NASDAQ:STAA) Is Looking To Continue Growing Its Returns On Capital
Mar 12Should You Investigate STAAR Surgical Company (NASDAQ:STAA) At US$68.56?
Feb 13Here's Why We Think STAAR Surgical (NASDAQ:STAA) Might Deserve Your Attention Today
Jan 28Calculating The Fair Value Of STAAR Surgical Company (NASDAQ:STAA)
Dec 15The Return Trends At STAAR Surgical (NASDAQ:STAA) Look Promising
Dec 01What Is STAAR Surgical Company's (NASDAQ:STAA) Share Price Doing?
Oct 26Keep Adding To STAAR Surgical Longs, Buy Thesis Remains
Sep 20Should You Be Adding STAAR Surgical (NASDAQ:STAA) To Your Watchlist Today?
Sep 05STAAR Surgical Company (NASDAQ:STAA) Shares Could Be 24% Above Their Intrinsic Value Estimate
Aug 21STAAR Surgical rises 15% on Q2 result beat
Aug 11주주 수익률
| STAA | US Medical Equipment | US 마켓 | |
|---|---|---|---|
| 7D | 22.5% | -0.6% | 0.9% |
| 1Y | -7.3% | 20.8% | 32.3% |
수익률 대 산업: STAA 지난 1년 동안 10.3 %를 반환한 US Medical Equipment 업계보다 저조한 성과를 냈습니다.
수익률 대 시장: STAA 지난 1년 동안 24.7 %를 반환한 US 시장보다 저조한 성과를 냈습니다.
가격 변동성
| STAA volatility | |
|---|---|
| STAA Average Weekly Movement | 9.1% |
| Medical Equipment Industry Average Movement | 8.8% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 14.8% |
| 10% least volatile stocks in US Market | 3.2% |
안정적인 주가: STAA 의 주가는 지난 3개월 동안 변동성이 심했습니다.
시간에 따른 변동성: STAA 의 주간 변동성( 8% )은 지난 1년 동안 안정적인 모습을 보였습니다.
회사 소개
| 설립 | 직원 | CEO | 웹사이트 |
|---|---|---|---|
| 1982 | 1,057 | Tom Frinzi | www.staar.com |
스타 서지컬 컴퍼니는 자회사와 함께 안구용 이식형 렌즈와 렌즈를 안구에 전달하는 동반 전달 시스템을 설계, 개발, 제조, 마케팅 및 판매하고 있습니다. 이 회사는 근시, 원시, 난시, 노안과 같은 시각 장애를 치료하는 이식형 콜라머 렌즈 제품군(ICL)을 제공합니다. 안과 의사, 안과 및 수술 센터, 병원, 정부 시설, 유통업체 등 의료 서비스 제공업체를 대상으로 제품을 판매하며, 안과 전문의가 주로 제품을 사용합니다.
STAAR Surgical Company 기본 사항 요약
| STAA 기본 통계 | |
|---|---|
| 시가총액 | US$1.83b |
| 수익(TTM) | US$16.61m |
| 수익(TTM) | US$332.94m |
110.2x
P/E 비율5.5x
P/S 비율STAA 주가가 과대평가되어 있나요?
공정 가치 및 가치 분석 보기수익 및 수익
| STAA 손익 계산서(TTM) | |
|---|---|
| 수익 | US$332.94m |
| 수익 비용 | US$69.13m |
| 총 이익 | US$263.81m |
| 기타 비용 | US$247.20m |
| 수익 | US$16.61m |
최근 보고된 수익
Jun 28, 2024
다음 수익 날짜
n/a
| 주당 순이익(EPS) | 0.34 |
| 총 마진 | 79.24% |
| 순이익 마진 | 4.99% |
| 부채/자본 비율 | 0% |
STAA 의 장기적인 성과는 어땠나요?
과거 실적 및 비교 보기